L-fucose-dependent biofilm formation by Escherichia coli enhances polymicrobial interactions and antibiotic tolerance

Steven M Taddei1, Namrata Deka1, Adam Marin1

  • 1Department of Microbiology and Immunology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA.

Biofilm
|July 3, 2026
PubMed

Insights

Polymicrobial interactions between three key bacteria significantly enhance urinary catheter biofilm formation and antibiotic resistance. Escherichia coli plays a crucial role in this process, particularly through its L-fucose utilization pathway.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biotechnology

Background:

  • Urinary tract infections (UTIs) are common healthcare-associated infections, often linked to indwelling catheters.
  • Long-term catheterization leads to persistent, asymptomatic polymicrobial colonization, even with interventions.
  • Key co-colonizing species include *Proteus mirabilis*, *Enterococcus faecalis*, and *Escherichia coli*.

Purpose of the Study:

  • To investigate the impact of interactions between *P. mirabilis*, *E. faecalis*, and *E. coli* on urinary catheter biofilm formation.
  • To understand the mechanisms driving enhanced biofilm biomass and colonization in polymicrobial communities.
  • To assess the role of microbial interactions in antibiotic resistance within catheter biofilms.

Main Methods:

  • Utilized a biofilm reactor model with silicone urinary catheters under flow conditions.
  • Analyzed biofilm biomass, total protein content, and species-specific contributions.
  • Employed proteomics to identify key metabolic pathways involved in biofilm enhancement.
  • Tested antibiotic resistance profiles of triple-species biofilms against ciprofloxacin and nitrofurantoin.

Main Results:

  • Triple-species biofilms (*P. mirabilis*, *E. faecalis*, *E. coli*) exhibited significantly enhanced biomass compared to dual-species or single-species biofilms.
  • Biofilm enhancement was dependent on the presence of all three species and specific media conditions.
  • *E. coli* was identified as a key facilitator of biofilm enhancement, particularly under flow conditions.
  • Proteomics revealed that an L-fucose utilization pathway in *E. coli* is critical for this enhancement.
  • Triple-species biofilms showed increased resistance to ciprofloxacin and nitrofurantoin.

Conclusions:

  • Polymicrobial interactions profoundly influence biofilm formation and colonization on urinary catheters.
  • The interplay between *P. mirabilis*, *E. faecalis*, and *E. coli* drives enhanced biofilm development and antibiotic resistance.
  • *E. coli*'s L-fucose utilization pathway is a significant factor in catheter-associated polymicrobial biofilm formation.